1/73
Looks like no tags are added yet.
What would happen to DNA if topoisomerase were inhibited during replication?
Replication cannot proceed because the DNA cannot “open” to become accessible to DNA polymerase
Why does the antibiotic Cirpoflaxin (which inhibits topoisomerase) kill bacteria without harming human cells?
Although both human and bacterial topoisomerases have the same function, they have different structures
It only inhibits the bacterial topoisomerase structure, leaving the human one unaffected
How does the anti-HIV drug AZT work to prevent HIV replication?
HIV uses an RNA-dependent DNA polymerase (reverse transcriptase) that has a high affinity for AZT and incorporates it into viral DNA instead of thymidine
This works because AZT has an azide group at its 3’ carbon instead of a normal hydroxyl group (-OH)
Because it lacks the free 3’ OH group, the polymerase cannot attach the next incoming nucleotide, effectively terminating DNA chain elongation
Why do linear eukaryotic chromosomes shorten with each round of replication (the “end-replication problem”)?
When RNA primers are removed from the laggign strand at the ends of linear chromosomes, the resulting gap cannot be filled by standard DNA polymerase
This is because DNA polymerase can only add nucleotides onto a pre-existing free 3’ end that has a complimentary template to base-pair with
Since there is no upstream 3’ end to build from at the very tip, a small piece of DNA is lost each cycle
Senscence
A process where a cell ages and permanently stops dividing, but does not die
Triggered by progressive shortening of telomeres across multiple cell divisions, which eventually leads to DNA damage response/activation (or apoptosis if damage is severe)
Acts as an important tumor-suppression mechanism because, by stopping damaged cells from continuing to replicate, the body prevents them from potentially turning into cancer
Outcome is that cells enter a permanent state of cell cycle arrest
Telomerase
A ribonucleoprotein complex consisting of a protein component and a built-in RNA template component
Binds to the 3’ G-rich overhang of linear chromosomes and uses reverse transcription (synthesizing DNA from its RNA template) to lengthen the telomere, preventing the end-replication problem
How does telomerase elongate a chromosome?
Binding: Telomerase binds to the 3’ G-rich tail using its built-in RNA template for base pairing
Synthesis (Reverse Transcription): Telomerase adds complimentary DNA nucleotides to the 3’ end
Translocation: Telomerase slides down (translocates) to the newly extended 3’ end and repeats the process
Filling the Gap: Primase and DNA polymerase synthesize a complimentary strand to fill the remaining gap
Sealing: RNA primers are removed and DNA ligase seals the backbone
Telomerase in normal cells
Do not express hTERT (human telomerase reverse transcriptase) mRNA and have virtually zero telomerase activity
Their telomeres shorten with age/divisions until they reach senescence or apoptosis
Telomerase in cancer cells
High expression of hTERT (human telomerase reverse transcriptase) mRNA and active telomerase
How do telomeres and telomerase contribute to the ability of cancer cells to continually divide?
Cancer cells express active telomerase, which continually rebuilds and maintains the length of their telomeres
Because their telomeres do not shorten, cancer cells bypass senescence, allowing them to avoid cell cycle arrest and divide indefinently
Interphase
Cell growth and DNA duplication
Divided into G1, S, and G2 phases
Mitotic phase
Physical divisions of the cell via mitosis (nuclear division) and cytokinesis (cytoplasmic division)
G1 phase
The cell undergoes major cell growth and prepares for DNA synthesis
Number of cells decreases with cancer
S phase
DNA synthesis and replication take place
Each chromosome replicates so that it consists of two identical copies called sister chromatids attached at the centromere
Monitors for any DNA damage
Number of cells increase with cancer
G2
The cell continues final growth and preparation for mitosis
Number of cells increase with cancer
Kinetochore
A protein structure on the centromere that attaches to mitotic spindle microtubles
Prophase
Chromosomes condense, spindle fibers emerge from centrosome, nuclear envelope breaks down
Prometaphase
Chromosomes continue condensing, kinetochores appear, and mitotic spindle microtubules attach to kinetochores
Metaphase
Chromosomes line up at the metaphase plate (equator)
Each sister chromatid attacthes to spindle fibers from opposite poles
Anaphase
Centromeres split
Sister chromatids (now individual chromosomes) are pulled toward opposite poles
Cell begins to elongate
Telophase
Chromosomes arrive at opposite poles and decondense
Nuclear envelopes form around the new set
Spindle breaks down
Cytokinesis in animal cells
A cleavage furrow forms, pinching the cell into two
Cytokinesis in plant cells
Golgi vesicles fuse along the equator to form a cell plate, which develops into a new cell wall separating the daughter cells
G0 phase
A resting or quiescent state where cells are not actively dividing
Inactive phase outside of the normal cycle
Positive regulator proteins (Cdks and Cyclins)
Act like the “gas pedal” to push the cell cycle forward
Cyclins bind to and activate Cyclin-dependent kinases (Cdks)
The activated Cdk/cyclin complex phosphorylates target proteins involved in cell division and growth, allowing the cell to progress through checkpoints
Cyclins are synthesized and quickly degraded depending on the cell plate
Negative regulator proteins
Act like the “brakes” to stop or inhibit cell division
Cues are density-dependent inhibition, lack of nutrients, or DNA damage
G1 checkpoint
Checks for cell volume, sufficient nutrients/organelles, and DNA damage before entering S phase
G2 checkpoint
Checks that genome is completely replicated, cell volume is large, and there is no DNA damage before entering mitosis
M checkpoint (spindle checkpoint)
Checks for the proper attachment of each kinetochore to spindle fiber during metaphase before anaphase proceeds
Rb
A tumor-suppressor gene and part of an inhibitory pathway (acts as a brake)
When it is active (but unphosphorylated), it binds to and inactivates transcription regulation
When stimulated by growth factors, Cdk-cyclin phosphorylates it, inactivating it
This releases the transcription regulator, promoting transcription, translation, and cell proliferation
Loss-of-function mutations in both copies of this protein lead to constitutive transcription, unregulated proliferation, and cancer
p53
DNA damage activates protein kinases that phosphorylate, stabilize, and activate this protein
When active, this protein binds to the regulatory region of the p21 gene, stimulating transcription and translation of p21 mRNA
Loss of both alleles for this protein strongly predisposes an individual to tumors
p21
Acts as a Cdk inhibitor protein that binds to G1/S-Cdk and S-Cdk complexes, making them inactive and halting the cell cycle to allow for DNA repair (or trigger apoptosis if damage is unfixable)
Large and hydrophilic (water soluble)
Bind to cell-surface receptors on the plasma membrane
Small and hydrophobic (lipid soluble)
Steroid hormones
Pass directly through the plasma membrane to bind to intracellular receptors in the cytoplasm or nucleus, often activing directly as transcription factors
Autocrine
A cell targets itself (signals to its own receptors)
Juxtacrine (Direct)
Cells communicate through direct physical contact
Paracrine
A cell signals to nearby target cells via local diffusion
Endocrine
A cell signals to distant target cells via bloodstream (using hormones)
Growth characteristics of normal cells
Exhibit anchorage dependence (must anchor to a dish to divide) and density-dependent inhibition (stop dividing once they form a single layer)
Growth characteristics of cancer cells
Do not exhibit anchorage dependence or density-dependent inhibition; they continue dividing uncontrollably, poling up in overlapping clumps
Flow cytometry
Cells in suspension are stained with a fluorescent dye that binds to DNA
They pass through a laser
Higher fluorescence= more DNA per cell
Ion-channel coupled receptors
Open to close to let ions pass across the membrane when a signal binds
G-protein coupled receptors (GPCRs)
7-transmembrane receptors that interact with intracellular trimeric G proteins
Enzyme-coupled receptors
Function directly as enzymes or associate with enzymes that become activated upon ligand binding
Activation and deactivation steps of a G protein coupled with a GPCR
Activation: When a signaling molecule binds, the GPCR undergoes a shape change, allowing it to bind to the alpha subunits of the G protein. The alpha subunit exchanges bound GDP for GTP, becoming activated and dissociating from the alpha subunits to trigger downstream effects
Deactivation: The activated alpha subunit eventually hydrolyzes GTP to GDP, returning to its inactive state and rejoining the alpha complex
How do second messengers like cAMP function
Activated G proteins can stimulate enzymes like adenylyl cyclase (AC) to convert ATP into cAMP, a major second messenger that amplifies the signal and activates downstream kinases
Phosphorylation
A kinase adds a phosphate group (activating the protein) while a phosphatase removes it to turn off
GTP Binding/Hyrdolysis
Binding GTP turns GTP-binding proteins (like Ras and G proteins) on (active) while hydrolysis of GTP to GDP turns them off (inactive)
Ras
A proto-oncogene encoding a G protein that acts as a relay molecule in a stimulatory signaling pathway, driving normal cell division
Ras gain of function mutation
Produces a hyperactive Ras protein that continuously fires signals even when no growth factor is bound
This results in increased cell proliferation and can lead to cancer
MAPK pathway
A phosphorylation cascade consisting of three main tiers: MAPKKK (e.g., Raf) to MAPKK (e.g., MEK1/2) to MAPK (e.g., ERK1/2)
Each protein is activated sequentially via phosphorylation, using energy from ATP
Active MAPK (ERK1/2) can enter the nucleus to phosphorylate transcription factors (like Fos, Elk-1, and CREB) that promote cell proliferation and survival
Feedback regulation within the MAPK pathway
Active ERK1/2 can exert negative feedback by inhibiting upstream components of the pathway, specifically Raf (MAPKKK) and MEK1/2 (MAPKK)
GAPDH
A housekeeping gene/protein included as a loading control
Its stable expression confirms that equal amounts of total protein were added to each lane
pERK1/2/pCREB
Specific antibodies detect phosphorylated (activated) forms of these proteins to measure pathway activation
How do MAPK inhibitors affect the cell cycle and proliferation
Reduces the expression of proliferation-driving proteins like Cyclin D1 and Cyclin A, while increasing tumor-suppressor proteins
This causes proliferating cells to get stuck in the G1 and S phases, resulting in a signifcant reduction in cell division but an increase of activity in G1
Bax
A pro-apoptotic protein that promotes cell death and mitochondrial outer membrane permeabilization
Bcl-2
A pro-survival/anti-apoptotic protein that inhibits Bax and blocks apoptosis
Overexpressed by cancer cells to escape cell death and survive under stress
Why is combining an ERK1/2 inhibitor with an apoptotic signal an effective strategy against cancer cells?
While an apoptotic signal alone may fail because Bcl-2 keeps the cell alive, inhibiting ERK1/2 decreases Bcl-2 and increases Bax activity, allowing the cancer cells to successfully undergo apoptosis
Topipotent stem cells
Can differentiate into any cell type in either an embryo or an adult (all possible cell types)
Pluripotent stem cells
Can differentiate into most, but not all cell types in a multicellular organism (usually multiple tissues)
Multipotent stem cells
Can differentiate into multiple types of specialized cells within a specific adult tissue
Induced pluripotent stem cells (iPSCs)
Differentiated somatic cells that are reprogrammed in the lab back into a pluripotent state using specific transcription factors
Can be used for disease modeling, compound/drug screening, and cell-replacement theory
Phenotypes of cancer cells
Originate in specific tissue (e.g., carcinomas from epithelium)
Immortal
Ability to move (via metastasis)
Genetic abnormalities (mutations, abnormal chromosome numbers(
Can differentiate
Express high levels of telomerase
Phenotypes of stem cells
Originates from or resides in tissues (multipotent/iPS)
Immortal
Ability to move (during organogenesis and development)
Main a normal, stable genome matching the organism
Can differentiate
Express high levels of telomerase
Four primary cellular processes that take place during embryonic development
Cell proliferation and apoptosis: Cells divide via mitosis/cytokinses and/or undergo apoptosis at regular times and locations
Cell movement: Cells move from one location to another, driving morphological and shape changes
Cell differentiation: Undifferentiated stem cells specialize into specific cell types at precise times and locations
Cell communication: Cells coordinate via signaling pathways (direct cell-to-cell, paracrine, etc)
Why can different tissues express different sets of genes even though they share the exact same DNA?
While all cells contain the same DNA sequences and regulatory elements, different cell types contain different sets of transcription factors (activators and repressors)
A gene is transcribed only if the appropriate transcription factors are present to bind its specific regulatory elements and recruit RNA polymerase
Reporter assay
A genetic construct where a cell-specific promoter and enhancer region of a gene of interest is linked to the coding sequence of a visible reporter protein (such as GFP or luciferase)
By introducing this construct into an organism, scientists can track where and when the protein is expressed in living tissues by visualizing the fluorescent output
How does histone acetylation affect chromatin structure and gene expression?
Adding acetyl groups (-COCH3) neutralizes the positive charge of histone tails, weakening their electrostatic attraction to negatively charged DNA
This causes chromatin to reflex into an open, accessible structure called euchromatin
Transcription factors and RNA polymerase can easily access the DNA, which activates gene transcription
How does DNA methylation affect gene expression?
Adding methyl groups (-CH3) directly to DNA bases (such as cytosines at CpG islands) does not change the actual DNA sequence
Instead, these methyl tags physically block transcription factors from binding or attract proteins that compact chromatin into a tight, closed structure called heterochromatin, which turns genes off
Methylation of tumor suppressor genes in cancer
Tumor suppressor genes normally stop uncontrolled cell growth or trigger apoptosis
In cancer, these genes often undergo hypermethylation (abnormal over-methylation) at their promoters, which silences them and allows cancer cells to multiply unchecked
Methylation of proto-oncogenes in cancer
Proto-oncogenes normally stimulate normal cell growth
Hypomethylation (abnormal under-methylation) can inappropriately activate or overexpress these genes, driving excessive cell proliferation
Why are epigenetic modifications promising targets for cancer treatments?
Unlike permanent DN sequence mutations, epigenetic modifications are reversible
Epigenetic therapies (such as DNA methyltransferase inhibitors) can remove abnormal methyl groups to reactive silenced tumor suppressor genes and halt cancer cell growth
Genome
Complete, rigid, and stable set of genetic instructions (DNA sequence) encoded in an organism
Changes (mutations) are usually permanent
Epigenome
The dynamic layer or chemical tags (like DNS methylation and histone acetylation) sitting on top of the DNA
It changes readily in response to the environment, diet, stress, and cell differentiation